News

Leggett & Platt Faces Challenges Amid Revised Earnings Outlook

Leggett & Platt Faces Challenges Amid Revised Earnings Outlook

Leggett & Platt's Recent Earnings Report Highlights Concerns

Leggett & Platt (NYSE: LEG), a well-established diversified manufacturer, is experiencing significant challenges in the market. Following the release of its third-quarter earnings, the company's shares took a notable dip of 5.4%. This decline came after the firm reported results that fell short of analyst expectations while also revising its full-year guidance downward.

Financial Performance Misses Expectations

For the third quarter, Leggett & Platt announced adjusted earnings per share of $0.32, which was a slight disappointment for investors as it missed the consensus estimate of $0.33. Although the company reported revenue of $1.1 billion, aligning with industry expectations, it represented a 6% decrease compared to the same quarter last year. These figures paint a concerning picture of the company's current performance.

Revised Earnings Guidance

In its recent forecast, Leggett & Platt lowered its adjusted earnings per share guidance for 2024 to a range between $1.00 and $1.10. This adjustment is below the previously anticipated consensus of $1.14, indicating that analysts are now more cautious regarding the company's future performance. The revenue projection also saw a reduction, as the company now anticipates earnings between $4.3 billion and $4.4 billion, compared to the earlier forecast of $4.3 billion to $4.5 billion.

Challenges in Key Markets

President and CEO Karl Glassman expressed concerns about weak demand in the company's residential markets, which he predicts will continue through the fourth quarter. Glassman cited a challenging macroeconomic environment and declining consumer spending as key hurdles. The automotive sector is also under pressure as Leggett & Platt navigates the transition to electric vehicles, grappling with affordability issues and economic struggles in Europe.

Sales Declines Across Major Segments

Leggett & Platt's organic sales experienced a 6% decline, primarily driven by a 4% drop in volume across its various key segments. Notably, the Bedding Products category suffered an 8% year-over-year decrease in sales. Similarly, the Specialized Products and Furniture, Flooring & Textile Products segments reported declines of 6% and 4%, respectively. These figures illustrate the firm’s need to reassess its strategies across different sectors.

Restructuring Efforts Show Progress

Despite the market challenges, Leggett & Platt is making strides in its restructuring initiatives. The company successfully paid down $124 million of debt during the quarter. Looking ahead, it anticipates realizing an annualized EBIT benefit of $50 million to $60 million from its restructuring by late 2025, a revision upward from the previous estimate of $40 million to $50 million.

Industry Outlook and Future Projections

The overall outlook for Leggett & Platt will depend on several factors, including consumer buying behavior and the ongoing transition within the automotive market. As the firm strives to recover from these setbacks, it must also navigate these external pressures while staying committed to its strategic restructuring goals.

Frequently Asked Questions

What caused Leggett & Platt's share price to drop?

The drop in share price was primarily due to the company reporting third-quarter earnings that missed analyst expectations and subsequently lowering its full-year guidance.

How much did Leggett & Platt lower its earnings guidance?

Leggett & Platt lowered its adjusted earnings per share guidance for 2024 to between $1.00 and $1.10, down from the previous consensus of $1.14.

What challenges is Leggett & Platt facing in its markets?

The company is experiencing weaknesses in residential end markets and headwinds in its automotive business, particularly concerning the transition to electric vehicles and economic conditions in Europe.

What steps is Leggett & Platt taking to address its debt?

Leggett & Platt successfully paid down $124 million of debt in the most recent quarter as part of its restructuring initiatives.

How does the company plan to benefit from its restructuring?

The company expects to realize an annualized EBIT benefit of $50 million to $60 million from restructuring by late 2025, showing an improvement from earlier estimates.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Aethlon's Merger Moves: High Stakes and High Hopes

Updated Category News Views 11

Two-Step Merger Raises Eyebrows It's not every day you see a company like Aethlon Medical, Inc. (NASDAQ: AEMD) shake up its core operations with a bold merger move. On September 17, 2026, Aethlon signed off on a Plan of Merger and Reorganization with North Immunology, Inc.—a clear signal to investors that the winds of change are blowing strong. Implications of the...

Continue Reading
Kroll's Geoeconomic Risk Index: A Financial Sentinel

Updated Category News Views 133

Diving into Kroll's New Geoeconomic Risk Index When global storms brew, businesses yearn for a reliable compass. In swoops Kroll with its Geoeconomic Risk Index—a new tool aimed at taking the mystique out of geopolitical and economic uncertainties to forecast their impact on businesses' bottom lines. Understanding the Index This isn't just another fancy gadget for the...

Continue Reading
Purina Targets Feline Health with New Nutrition Line

Updated Category News Views 51

Investing in Cat Care: Purina's Bold Move Stop the presses! Purina Pro Plan Veterinary has a new game in town, and it's all about cats. If you've got a soft spot for these furry felines—or a portfolio that leans towards retail and pharmaceuticals—this one's going to perk your ears. Purina's seizing the moment to boost its veterinary portfolio, diving headfirst into...

Continue Reading
Miami Gala Raises $200K for Teen Emotional Health

Updated Category News Views 91

A Night of Giving and Growth in Miami Ever felt like a single evening could change the world? Well, that's exactly what happened on November 7th at the Britto Palace in Miami. The Ismael Cala Foundation pulled off a remarkable feat, raising over $200,000 to boost emotional intelligence among teens through its annual gala, Legacy of Light: A Night of Joyful Giving. The...

Continue Reading
The Spice & Tea Exchange® Hits 100 Store Milestone

Updated Category News Views 54

Reaching the Century Mark in Retail Ah, retail. It's a rough-and-tumble world out there, but today we're tipping our hats to The Spice & Tea Exchange® for hitting the 100-store milestone. This brand's fresh out the kitchen with a shiny new store in Eureka Springs, Arkansas, marking a big moment for a franchise that's become a hot commodity in the realm of spices and...

Continue Reading
Omni Helicopters Secures $38M in New Financing Deals

Updated Category News Views 80

Omni Helicopters Charts New Financial Horizons When Omni Helicopters International (OHI) rawly gathers R$200 million under its financial belt, it’s clear someone’s eyeing horizons beyond the immediate. This hefty chunk, clocking in at roughly $38 million, emerges from a duo of noteworthy financing facilities and marks a strategic maneuver as OHI aligns itself for cash...

Continue Reading
Telecom Argentina's 2026 Financial Rollercoaster Ride

Updated Category News Views 46

Analyzing Telecom Argentina's Financial Turmoil Telecom Argentina's nine-month stretch of 2026 wasn’t a smooth sail by any stretch. The powerhouse saw a consolidated net loss of P$56,615 million for the third quarter while bagging a net income of P$862,959 million across the broader period. Talk about volatility. It's a classic case of juggling financial fire,...

Continue Reading
Gates Unveils ThermalCool 2100SS: A Game-Changer?

Updated Category News Views 24

Breaking into Unseen Data Center Challenges When you cram more computing power into a single rack than ever before, every single part better pull its weight. Gates Industrial Corporation Ltd. (NYSE: GTES) just threw down the gauntlet with their new toy: the ThermalCool™ 2100SS Pump. Number crunching ain't just about the processor or memory anymore. If the cooling system...

Continue Reading
Deadline Nears for Everest Group Class Action Plaintiffs

Updated Category News Views 50

Everest Group Faces Heavy Litigation Alright, folks, grab your mugs of caffeine and let's dive right into the mess Everest Group, Ltd. has found itself in. The clock is ticking for investors who've taken a punch in the gut between February 8, 2024, and October 27, 2025, courtesy of NYSE: EG. Lawyers are on the chase, and come December 28, 2026, the window to spearhead a...

Continue Reading
Kargo's Tech Boosts Profit on Seafood Supply Chain

Updated Category News Views 29

Revolutionizing Seafood Logistics with Kargo You'd think managing seafood shipments would be a simpler gig than charting ocean routes, but think again. Northern Wind, a major player in seafood processing, just proved the power of tech in an old-school business by partnering with a slick AI outfit called Kargo. Their facility in New Bedford, Massachusetts now magically...

Continue Reading

Top 5 Most Recently Viewed Articles

Varonis Systems Inc: Understanding Investor Sentiments

Updated Category News Views 175

Understanding Varonis Systems Inc's Short Interest Varonis Systems Inc (NYSE: VRNS) has seen a notable rise in its short interest, with recent data indicating a 10.92% increase since the last report. Currently, approximately 6.57 million shares are sold short, representing 6.3% of the total shares available for trading. This increase in short interest highlights an...

Continue Reading
Insight into Talkspace's Upcoming Earnings Report

Updated Category News Views 138

Overview of Talkspace's Earnings Forecast Talkspace Inc (NASDAQ: TALK) is set to release its quarterly earnings report soon. Investors are eager for insights into the company's performance and what the future may hold. Analysts have projected an earnings per share (EPS) of $0.01, making this an important milestone for the company's financial trajectory. Expectations for...

Continue Reading
Insightful Look Ahead: Pathward Financial's Earnings Update

Updated Category News Views 48

Anticipating Pathward Financial's Earnings Results Pathward Financial (NASDAQ: CASH) is gearing up for its highly anticipated quarterly earnings release. Investors are eagerly awaiting the announcement, which is set to take place on an upcoming Wednesday. To ensure that you are well-prepared, here is a comprehensive overview of what to consider leading up to this...

Continue Reading
Soleno Therapeutics Receives Positive FDA News, Anticipates Growth

Updated Category News Views 86

Positive FDA Update Sparks Anticipation for Soleno Therapeutics Recently, Soleno Therapeutics Inc. (NASDAQ: SLNO) received encouraging news from the U.S. Food and Drug Administration (FDA). The regulatory body has indicated that no advisory committee meeting is necessary for the assessment of the company's promising drug, DCCR. This development relates to the review of...

Continue Reading
Conrad Industries Sees Big Backlog, Challenges Persist

Updated Category News Views 49

Conrad Industries Shows Resilience with Strong Backlog When Conrad Industries throws their hat in the ring with quarterly results, folks like us can't help but sit up and take notice. Why? Because even though their profits took a hit, the backlog numbers are mouthwatering. Let’s dig into the nitty-gritty. Quarterly Results: A Mixed Bag For the numbers crunchers,...

Continue Reading